Prospective validation of the PML risk biomarker L-selectin and influence of natalizumab extended intervals

Affiliation auteurs!!!! Error affiliation !!!!
TitreProspective validation of the PML risk biomarker L-selectin and influence of natalizumab extended intervals
Type de publicationJournal Article
Year of Publication2019
AuteursSchwab N, Schneider-Hohendorf T, Pignolet B, Bucciarelli F, Scandella L, Ciron J, Biotti D, Lebrun-Frenay C, Mathey G, Clavelou P, Pelletier J, Ostkamp P, Meinl I, Windhagen S, Klotz L, Gross CC, Meuth SG, Deisenhammer F, Brassat D, Wiendl H, Martinez M, Heinzlef O, Zephir H, Anne O, Audoin B, Bensa C, Berger E, Cabre P, Castelnovo G, Collongues N, Coustans M, Creange A, Dive D, Edan G, Fromont A, Gout O, Gouider R, Grimaud J, Hautecoeur P, Kiatkoswki A, LePage E, Marignier R, Moreau T, Ouallet J-C, Papeix C, Rumbach L, Seeldrayers P, Sennou ISlassi, Stankoff B, Tourbah A, Thouvenot E, Vermersch P, Grp B-MSStudy
JournalNEUROLOGY
Volume93
Pagination550-554
Date PublishedSEP 17
Type of ArticleArticle
ISSN0028-3878
DOI10.1212/WNL.0000000000008135